Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting

about

Fluid biomarker agreement and interrelation in dementia due to Alzheimer's disease.Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort.

P2860

Q47573970-849F5F9F-A77E-41BD-9C6E-FFAB7C71657E Q47942128-1A819802-1BD9-4D7B-8958-1AF8F67DA41F

P2860

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting

Item

http://www.wikidata.org/entity/Q37387826

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Are CSF Biomarkers Useful as P ...... s in a Normal Clinical Setting

@en

Are CSF Biomarkers Useful as P ...... in a Normal Clinical Setting.

@nl

type

Item

label

Are CSF Biomarkers Useful as P ...... s in a Normal Clinical Setting

@en

Are CSF Biomarkers Useful as P ...... in a Normal Clinical Setting.

@nl

prefLabel

Are CSF Biomarkers Useful as P ...... s in a Normal Clinical Setting

@en

Are CSF Biomarkers Useful as P ...... in a Normal Clinical Setting.

@nl

P1476

Are CSF Biomarkers Useful as P ...... s in a Normal Clinical Setting

@en

P2093

Malene Schjønning Nielsen

http://www.w3.org/2001/XMLSchema#string

Peter Høgh

http://www.w3.org/2001/XMLSchema#string

Volkert Siersma

http://www.w3.org/2001/XMLSchema#string

P2860

Testing the right target and right drug at the right stage

Blood-brain barrier alterations in ageing and dementia

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis.

The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia

Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.

P304

465-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000449410

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steen G. Hasselbalch

Anja H. Simonsen

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27843444

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5091222

http://www.w3.org/2001/XMLSchema#string

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting

about

P2860

P2860

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932